Status:
COMPLETED
Effect of Allium Cepa in the Management of Shoulder Pain Post Stroke
Lead Sponsor:
Bayero University Kano, Nigeria
Collaborating Sponsors:
Physiotherapy Associates
Conditions:
Stroke
Eligibility:
All Genders
18-65 years
Phase:
EARLY_PHASE1
Brief Summary
One of the disabling consequences of stroke is hemipleic shoulder pain. Hemiplegic shoulder pain could be most important hinderance to upper extremity function after stroke . Evidence for rehabilitati...
Detailed Description
Globally, stroke is the second most common cause of death and a major cause of disability. One of the disabling consequences of stroke is hemipleic shoulder pain which on its own could result in disab...
Eligibility Criteria
Inclusion
- Participants who had hemiplegic shoulder pain after stroke with age range of 18 years and above who are able to express pain level and communicate in general
Exclusion
- Stroke survivors with significant cognitive impairment (\< 18 on a mini mental scale) and language impairment that would prevent the patient from answering questions reliably.
- Stroke survivors who had sustained shoulder pain caused by condition other than hemiplegia such as fracture, vertebral origin, dislocation, inflammatory arthritis (rheumatoid and gout) and fibromyalgia.
- Participants who exhibit allergy to Allium Cepa (skin sensitivity or finds the odor offensive).
- Participants who do not agree to use Allium Cepa
Key Trial Info
Start Date :
June 11 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 14 2019
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT03468049
Start Date
June 11 2018
End Date
June 14 2019
Last Update
November 6 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amina Kano Teaching Hospital
Kano, Nigeria, +234